Erythromycin (as lactobionate) inj 1g vial: supply issue

Supply issue Active

Due to manufacturing delays, Erythromycin (as lactobionate) inj 1g vial (Pharmacode: 2270234) is low in stock. Pharmac has funded new products to ensure continuity of supply

Affected product

  • Chemical: Erythromycin (as lactobionate)
  • Presentation: Inj 1 g vial
  • Brand: Erythrocin IV
  • Pharmacode: 2270234
  • Subsidy: $10.00
  • Measure / Qty: per 1

Schedule listing for Erythromycin (as lactobionate)(external link)

HML listing for Erythromycin (as lactobionate)(external link)

Alternative products

From 1 August Pharmac will fund two alternate products, erythromycin 1 g vial (Amdipharm) and erythromycin 500 mg vial (Eritrotex). The alternate brands are not a Medsafe approved product and should be prescribed and supplied in line with Section 29A of the Medicines Act.

Erythromycin 1 g vial

  • Chemical: Erythromycin (as lactobionate)
  • Presentation: Inj 1 g vial
  • Brand: Erythromycin-Amdipharm
  • Pharmacode: 2734125
  • Subsidy: $125.95
  • Measure / Qty: per 1
  • Medsafe Approved: No (Section 29A medicine)

Erythromycin 500 mg vial

  • Chemical: Erythromycin (as lactobionate)
  • Presentation: Inj 500 mg vial
  • Brand: Eritrotex
  • Pharmacode: 2734117
  • Subsidy: $59.95
  • Measure / Qty: per 1

Medicine not Medsafe reviewed 

Prescribing and supplying an unapproved medicine 

Section 29A of the Medicines Act 1981 allows for medicines that are not Medsafe approved to be prescribed and supplied to people when there is supply issue affecting the registered brand.  

We know supplying an unapproved medicine is not ideal. In this case, however, this will allow people to continue to access an appropriate treatment.  

We apologise for any inconvenience this causes.  

Prescriber and pharmacist requirements for section 29 and 29A medicines – Medsafe website (external link)(external link) 

What patients need to know about unapproved medicines – Healthify website(external link)(external link) 

Expected resolution

We are working with the supplier to understand when the next shipment of the Medsafe-approved product will be available. 

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.

Sign up to our email list for regular emails about supply issues and more(external link)